Skip to content
Disclosery

BOONE CAPITAL MANAGEMENT LLC

Follow

13F filer, CIK 1882053, ATLANTA, GA

BOONE CAPITAL MANAGEMENT LLC reported $293,830,546 across 12 holdings for the quarter ended 2025-03-31, in a 13F-HR filed 2025-05-15. Its ten largest share positions make up 92.53% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001214659-25-007815

Period
2025-03-31
Reported value
$294M
Holdings
12
Top 10 weight
92.53%
New
3
Sold out
4

Largest buys vs the previous quarter

SecurityShares changeApprox. value
MDTnew+393,737$35.4M
BMRNnew+327,279$23.1M
ISRGnew+38,930$19.3M
PNTGadded+77,882$1.96M
MIRMadded+21,475$967K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
GMEDreduced-207,701-$15.2M
IDYAexited-524,868-$13.5M
IQVexited-57,141-$11.2M
GNWexited-1,536,612-$10.7M
PRGOreduced-317,545-$8.9M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2025

Share positions as resolved from 13F-HR 0001214659-25-007815, largest first. % of portfolio is the value over $293,830,546, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
UNMUNUM GROUPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 964,170 shares; 2024Q4: 803,865 shares; 2025Q1: 700,600 shares 700,600$57.1M19.42%-103,265Timeline
MDTMEDTRONIC PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 393,737 shares 393,737$35.4M12.04%newTimeline
MIRMMIRUM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 543,843 shares; 2024Q4: 581,843 shares; 2025Q1: 603,318 shares 603,318$27.2M9.25%+21,475Timeline
GMEDGLOBUS MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 651,710 shares; 2024Q4: 568,465 shares; 2025Q1: 360,764 shares 360,764$26.4M8.99%-207,701Timeline
CITHE CIGNA GROUPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 131,926 shares; 2024Q4: 85,861 shares; 2025Q1: 70,859 shares 70,859$23.3M7.93%-15,002Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 327,279 shares 327,279$23.1M7.87%newTimeline
MOHMOLINA HEALTHCARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 71,704 shares; 2024Q4: 81,842 shares; 2025Q1: 67,555 shares 67,555$22.3M7.57%-14,287Timeline
PRGOPERRIGO CO PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 452,221 shares; 2024Q4: 1,022,369 shares; 2025Q1: 704,824 shares 704,824$19.8M6.73%-317,545Timeline
ISRGINTUITIVE SURGICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 38,930 shares 38,930$19.3M6.56%newTimeline
PNTGPENNANT GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 641,255 shares; 2024Q4: 641,255 shares; 2025Q1: 719,137 shares 719,137$18.1M6.16%+77,882Timeline
OFIXORTHOFIX MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 930,507 shares; 2024Q4: 1,057,313 shares; 2025Q1: 948,202 shares 948,202$15.5M5.26%-109,111Timeline
BHVNBIOHAVEN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 361,420 shares; 2025Q1: 270,198 shares 270,198$6.5M2.21%-91,222Timeline

Sold out in Q1 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
IDYAIDEAYA BIOSCIENCES INC524,868$13.5Mshares
IQVIQVIA HLDGS INC57,141$11.2Mshares
GNWGENWORTH FINL INC1,536,612$10.7Mshares
VKTXVIKING THERAPEUTICS INC209,853$8.44Mshares

How Q1 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001214659-25-007815 base2025-05-15acceptance time not in the bulk data set